U.S., Feb. 8 -- ClinicalTrials.gov registry received information related to the study (NCT06815172) titled 'PARA (Pancreatic Adenocarcinoma Etiology: Role of Asbestos) Study of Risk Factors for Exocrine Pancreatic Neoplasms.' on Jan. 10.
Brief Summary: The primary objective of the study will be to evaluate the possible association between asbestos exposure (occupational, paraoccupational, environmental and non-occupational) and pancreatic adenocarcinoma. The data collected will be used to generate specific hypotheses on the possible environmental and occupational determinants of the disease.
The study aims to evaluate:
1. To evaluate the exposure to asbestos occurred during life, through the use of a standardized questionnaire to be admi...